Abstract:In systems biology and pharmacology, large-scale kinetic models are used to study the dynamic response of a system to a specific input or stimulus. While in many applications, a deeper understanding of the input-response behaviour is highly desirable, it is often hindered by the large number of molecular species and the complexity of the interactions. An approach that identifies key molecular species for a given input-response relationship and characterises dynamic properties of states is therefore highly desirable. We introduce the concept of index analysis; it is based on different time- and state-dependent quantities (indices) to identify important dynamic characteristics of molecular species. All indices are defined for a specific pair of input and response variables as well as for a specific magnitude of the input. In application to a large-scale kinetic model of the EGFR signalling cascade, we identified different phases of signal transduction, the peculiar role of Phosphatase3 during signal activation and Ras recycling during signal onset. In addition, we discuss the challenges and pitfalls of interpreting the relevance of molecular species based on knock-out simulation studies, and provide an alternative view on conflicting results on the importance of parallel EGFR downstream pathways. Beyond the applications in model interpretation, index analysis is envisioned to be a valuable tool in model reduction. In systems biology, the response of signalling networks to various molecular stimuli is studied through large and complex kinetic models. Prominent examples include the epidermal growth factor receptor signalling cascade and its response to growth factors or therapeutic interventions by small molecules and therapeutic protein drugs. The design of targeted interventions requires a detailed understanding of the signalling cascade, the identification of key molecular constituents and their functional role in propagating the signal. A quantitative analysis of such systems, however, is challenging due the size of the model and the complexity of molecular interactions. We present an approach based on time- and state dependent quantities that are called indices and quantify different characteristic dynamic features of the molecular constituents. This allows for a more in-depth understanding of how the signal propagates through the network and elicits its response. Our findings for the epidermal growth factor receptor signalling cascade provide new insights on the dynamic interplay of key molecular players.

Algebraic Study of Receptor-Ligand Systems: A Dose-Response Analysis

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Modeling Biphasic, Non-Sigmoidal Dose-Response Relationships: Comparison of Brain-Cousens and Cedergreen Models for a Biochemical Dataset

Adaptive designs for identifying optimal biological dose for molecularly targeted agents.

Quantification of Signal Amplification for Receptors: The K /EC Ratio of Full Agonists as a Gain Parameter

The receptor-toxin-antibody interaction: Mathematical model and numerical simulation

Application of an Allosteric Ternary Complex Model to the Technique of Pharmacological Resultant Analysis

A 19F-qNMR-Guided Mathematical Model for G Protein-Coupled Receptor Signaling

Robust and Efficient Assessment of Potency (REAP) as a quantitative tool for dose-response curve estimation

Therapeutic algebra of immunomodulatory drug responses at single-cell resolution

Quantitative Analysis of Ligand Induced Heterodimerization of Two Distinct Receptors

A Formal Model For Analyzing Drug Combination Effects And Its Application In Tnf-Alpha-Induced Nf Kappa B Pathway

Allovalency revisited: An analysis of multisite phosphorylation and substrate rebinding

A Computational Workflow for Refining AF2 Models in Drug Design Using Kinetic and Thermodynamic Binding Calculations: A Case Study for the Unresolved Inactive human Adenosine A3 Receptor

Receptor Surface Models. 2. Application to Quantitative Structure-Activity Relationships Studies

Quantitative Modeling of Dose–response and Drug Combination Based on Pathway Network

Simple and Versatile Pharmacokinetic Model for Radioligand Therapy

Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathway

Analysis of multidrug effects by parameter method

Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors

Recent Advances in the Quantitative Determination of Protein Receptor–Ligand Interaction Kinetics